Find Academic Supervisors

Clinical Associate Professor Keith Ong is affiliated with the University of Sydney’s Northern Clinical School, specifically within the Department of Clinical Ophthalmology & Eye Health. His clinical specialty is Ophthalmology, with a focus on corneal endothelial health, glaucoma surgery outcomes, and cataract surgical techniques. His research addresses critical areas such as postoperative ocular toxicity, intraocular lens calculations, and infection control in eye surgeries. Dr. Ong’s publications (2011–2023) consistently explore topics like corneal endothelial changes post-trabeculectomy, refractive error management post-cataract surgery, and antibiotic prophylaxis strategies. Recent work emphasizes optimizing surgical techniques to reduce complications, such as BAK-induced corneal toxicity and IOL power calculation accuracy in LASIK patients. His work demonstrates a focus on improving surgical safety and precision, with studies evaluating alternative antibiotic delivery methods and laser therapy impacts. No awards or grants are explicitly noted in the provided text, but his contributions to clinical practice and surgical protocols are evident through his publication record.

• Ophthalmology
• Corneal Endothelial Health
• Cataract Surgery Outcomes
• +3 more

Dr. John Males is a Clinical Senior Lecturer at the University of Sydney and Director of Ophthalmology Training at Sydney Eye Hospital. His clinical and research expertise focuses on corneal surgery, cataract surgery, and laser vision correction. He pioneered Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) in Australia and is conducting clinical trials on Collagen Cross-Linking for keratoconus. His research spans corneal transplantation techniques, refractive error management, and ocular surface regeneration. Dr. Males holds roles as a consultant at major hospitals and serves as an examiner for the Royal Australian & New Zealand College of Ophthalmologists. Research interests include corneal biomechanics, surgical innovation for keratoconus, and outcomes analysis of cross-linking therapies. He leads studies on corneal densitometry, dry eye correlations, and long-term efficacy of surgical interventions. His work bridges clinical practice with translational research in regenerative medicine and ocular surface engineering. Publications span over 20 years, emphasizing corneal transplantation advancements, keratoconus management, and surgical complication resolution. His contributions to global consensus guidelines for endothelial keratoplasty highlight leadership in standardizing surgical practices.

• Ophthalmology
• Corneal Surgery
• Laser Vision Correction
• +3 more

Professor Gerard Sutton is an Honorary Professor in the Faculty of Medicine and Health at the University of Sydney, affiliated with the Save Sight Institute and Vision Eye Institute. He specializes in corneal and refractive surgery, combining clinical practice with research in keratoconus, corneal bioengineering, and global eye care. His work includes developing the Australian Corneal Bioengineering Centre and pioneering innovations like the Corneal Biopen for treating corneal defects. Research interests span clinical and laboratory-based studies, focusing on corneal transplantation, bioengineered treatments, and refractive surgery outcomes. Current projects include corneal bioengineering, keratoconus pathogenesis, and SMILE surgery clinical outcomes. He holds memberships in prominent ophthalmology societies like RANZCO and APPO. Awards: 2019 RANZCO John C. Parr Medal Lecture Award 2017 Sydney Research Centre ‘Big Idea’ Innovation Award 2015 XOVA Excellence in International Ophthalmology 2014 Asia Pacific Academy of Ophthalmology Achievement Award Grants & Funding: AU$35M BIENCO consortium (2023) for corneal blindness therapies AU$1.1M Corneal Biopen commercialization (2018) NHMRC Ideas Grant for bioengineered corneal layers (2019) His research group collaborates internationally, with projects addressing corneal transplantation equity, bioink development, and regenerative solutions for ocular surface diseases. Clinical affiliations include Sydney Eye Hospital and the Lions NSW Eye Bank.

• Ophthalmology
• Corneal Diseases
• Keratoconus
• +3 more

Professor Stephanie Watson OAM is a corneal surgeon and academic at the University of Sydney, leading the Corneal Research Group and serving as Head of the Corneal Unit at Sydney Eye Hospital. She holds leadership roles in Sydney Nano as co-Deputy Director for Industry, Innovation, and Commercialisation, and chairs key professional organizations including the Australian Vision Research Committee and the Asia Pacific Ophthalmic Trauma Society. Her clinical practice focuses on corneal and cataract surgery, with appointments at Sydney Eye Hospital, Sydney Children’s Hospital, and Prince of Wales Hospital. She is a RANZCO trainer and actively contributes to policy advocacy through roles in ARVO and other global bodies. Her research spans corneal therapies, keratoconus treatment via corneal cross-linking, dry eye disease management, and nanotechnology applications in ophthalmology. She leads the Save Sight Keratoconus and Dry Eye Registries, analyzing real-world patient outcomes and informing clinical guidelines. Her work bridges basic science (e.g., stem cell therapies) and clinical innovation (e.g., chitosan-based surgical adhesives), with notable contributions to antimicrobial resistance strategies in ocular infections and ocular trauma epidemiology. Professor Watson has been recognized with an Order of Australia Medal (OAM), the 2019 NSW Premier’s Prize for Science & Engineering, and global accolades including being named among the top 100 female ophthalmologists. Her research has driven advancements in corneal cross-linking techniques, dry eye quality-of-life metrics, and nanoparticle drug delivery systems. She actively engages in public education through media appearances, patient webinars (e.g., KeraClub series), and policy advocacy to address ocular health disparities. Her grants include projects on breast cancer chemotherapy’s ocular impact, AI-driven diagnosis of infectious keratitis, and high-throughput nanoparticle synthesis systems. She collaborates with industry partners like Brandon Capital and the Sydney Nano Institute, translating research into clinical solutions. Her leadership in international trauma registries (e.g., IGATES) advances global understanding of ocular injury patterns and preventive strategies.

• Corneal Therapies
• Keratoconus Treatment
• Dry Eye Disease
• +4 more

Clinical Associate Professor Tim Roberts is a cataract and glaucoma specialist at the University of Sydney and Royal North Shore Hospital. He holds a MBBS from UNSW, MMed from Sydney, and is a Fellow of RANZCO. His academic roles include Academic Lead for Ophthalmology at SERT Institute and Academic Coordinator at the Northern Clinical School. Education: MBBS (UNSW), Master of Medicine (Sydney), specialist training at Sydney Eye Hospital. Research focuses on femtosecond lasers, IOL power formulas, MIGS, and presbyopia-correcting lenses. He has published >60 articles and serves on editorial boards for major ophthalmology journals. Recent articles emphasize IOL technology advancements and surgical efficiency improvements. Awards include Global Achievement Awards from AAO and APACOS. Leadership roles include NSW QEC Chair and National Medical Director of Vision Eye Institute. Advises on >38 students via collaborative research projects. Labs/Teams: Leads surgical training programs at SERT Institute and collaborates with international eye care initiatives like Myanmar Eye Care Program.

• Cataract Surgery
• Glaucoma Management
• Intraocular Lens (IOL) Technology
• +6 more

Jeremiah Lim is a Senior Lecturer at the School of Allied Health within the Department of Optometry and Vision Science at The University of Western Australia. He holds a PhD in Neuroscience from the University of Melbourne, specializing in Alzheimer’s disease ocular phenotypes, and has additional qualifications in optometry and education. His research focuses on neurodegenerative diseases (Alzheimer’s/Parkinson’s), retinal imaging , and biomarkers , with particular emphasis on translating ocular findings to broader neurological insights. Key projects include retinal hyperspectral imaging in disease models and improving eye health literacy in disadvantaged communities. Recent work emphasizes mouse models for studying neurodegeneration, electrophysiology , and gene therapy applications. Lim has authored over 25 peer-reviewed articles, with notable contributions to retinal biomarker development and clinical optometry practices. Awards: Alexander-Guelma Clinical Fellow in Neuroscience (2019), Eberhard Dodt Memorial Award (2016) Grants: Perth Eye Foundation (2024–2027), Diabetes Research Foundation of WA (2024–2025) His interdisciplinary approach bridges optometry, neuroscience, and clinical practice, aiming to advance early disease detection and patient care strategies.

• Biomarkers
• Ocular imaging
• Electroretinography
• +7 more

Annette Hoskin is an Adjunct Senior Research Fellow at the School of Health and Clinical Sciences, specializing in Optometry and Vision Science at The University of Western Australia. Her research addresses critical issues in ocular health, particularly eye injuries, pediatric vision, and evidence-based ophthalmology practices. Her primary research interests include ophthalmology, eye injury mechanisms, vision science, systematic reviews, pediatric optometry, meta-analytical methods, eye protection strategies, visual acuity assessment, pharmacological agents affecting the eye, and cohort effect studies in vision disorders. She contributes to UN Sustainable Development Goals through this work. Recent publications (2025) demonstrate a strong focus on ocular trauma epidemiology, sports-related eye injuries, vitreoretinal pathologies, and advanced analytical methodologies like systematic reviews and finite element modeling. Research themes consistently emphasize clinical applications for injury prevention and treatment optimization.

• Ophthalmology
• Eye Injury
• Vision Science
• +7 more

Professor David Atchison is a distinguished academic at Queensland University of Technology (QUT), affiliated with the School of Optometry and Vision Science within the Faculty of Health. He holds a Professorship and has been a leading figure in visual optics research for over 35 years. His academic qualifications include a Doctor of Science (QUT), PhD (University of Melbourne), and advanced optometry degrees. Research Focus: Ophthalmic optics, myopia progression mechanisms, retinal shape analysis, and color vision. Key Contributions: Over 230 journal publications, 2 books, and significant grants from ARC and NHMRC. Awards: HB Collin Medal (2014), Glenn F. Fry Award (2011), and Fellowships from major optical societies. Teaching: Leads courses in optometry, including OPB353/453 (Ophthalmic Optics) and OPN164 (Research Methods). Research Interests: Explores the interplay between eye optics and visual performance, design of corrective lenses, and color vision deficiencies. Current projects include longitudinal studies on myopia progression in children and advanced imaging techniques for retinal morphology analysis.

• Ophthalmic Optics
• Visual Optics
• Myopia Research
• +3 more

Andrew White is a Clinical Associate Professor and clinician scientist ophthalmologist at the University of Sydney, affiliated with the Save Sight Institute and Westmead Institute for Medical Research. He specializes in glaucoma, holding roles as Head of the Department of Ophthalmology at Westmead Hospital and Director of the Community Eye Care Project (C-eye-C). His research focuses on neuroprotection in glaucoma, mechanisms of disease progression, and improving healthcare delivery through innovative techniques like smartphone-based diagnostics and low-cost surgeries. Education: B.Med.Sci (Hons) MBBS PhD from the University of Sydney (1995-2001), with postgraduate research at Max Planck Institute and SUNY. Clinical training included subspecialty glaucoma training at Sydney Eye Hospital, Westmead Hospital, and Addenbrooke’s Hospital (UK), where he was a Consultant Ophthalmologist and Senior Lecturer in Ophthalmology (2011). Research Interests: Neuroprotection strategies, glaucoma pathogenesis, SLT-associated corneal changes, and epidemiology of glaucoma in diverse populations. Active in clinical trials, including renin-angiotensin system modulation and genetic studies (ANZRAG). Key Awards: 2017 Western Sydney LHD Quality Award, Vision 2020 Rising Stars of Ophthalmology. Leadership roles include Co-chair of the Agency for Clinical Innovation’s Ophthalmology Governing Body, Board Member of Ophthalmic Research Institute of Australia, and advisory roles in global glaucoma organizations. Publications span neuroprotective agents, surgical innovations (e.g., Hydrus microstent), AI-driven glaucoma screening, and diabetic retinopathy screening programs. Collaborates internationally, notably with the University of Cambridge’s Centre for Brain Repair on neurodegenerative links.

• Glaucoma
• Neuroprotection
• Ophthalmology
• +3 more

Adjunct Associate Professor Alex Hui is a leading academic in ocular drug delivery and contact lens innovation at UNSW Sydney's School of Optometry and Vision Science. His work focuses on developing novel drug delivery systems via contact lenses for ocular diseases, including antibiotics, anti-inflammatory agents, and myopia control solutions. He holds advanced qualifications including a PhD in Vision Science from the University of Waterloo and is a Fellow of multiple professional optometry organizations. Research Interests: Dr. Hui's primary research includes drug-eluting contact lenses, antimicrobial therapies, myopia progression control, and ocular surface health. His interdisciplinary approach combines biomaterials engineering, clinical pharmacology, and vision science. His Myopia Research Group and Ocular Surface Research initiatives drive advancements in vision preservation and disease treatment. Education: PhD in Vision Science, University of Waterloo (2014) OD in Optometry, University of Waterloo (2010) GradCertOcTher, UNSW Sydney (2018) Awards and Recognition: Hui has received prestigious awards including the UNSW Vice-Chancellor's Teaching Excellence Award (2018), W.B Pearson Medal (2015), and multiple fellowships from the American Optometric Foundation. His research has been supported by grants from NSERC and the Australian Government. Labs and Teams: He leads the Ocular Therapeutics Lab and collaborates with the Myopia Research Group to advance drug delivery systems and contact lens technologies. His work bridges academia and clinical practice, emphasizing translational solutions for eye health challenges.

• Ocular Drug Delivery
• Contact Lens Technology
• Myopia Control
• +3 more

Ashish Agar serves as a Conjoint Professor at the University of New South Wales within the School of Clinical Medicine. His extensive academic career focuses primarily on ophthalmology, with particular expertise in glaucoma diagnosis, management, and innovative diagnostic techniques. Dr. Agar maintains active clinical and research roles, collaborating with numerous institutions and researchers across Australia. Dr. Agar's research interests span multiple domains within ophthalmology, with a strong emphasis on glaucoma diagnosis and management. His work investigates visual field testing methodologies, retinal imaging techniques, and optic nerve assessment protocols. He has pioneered research in low-cost diagnostic instruments for ophthalmic practice and has made significant contributions to understanding glaucoma progression patterns. Additionally, Dr. Agar has dedicated substantial effort to ophthalmology education , examining the current state of eye care training in medical schools globally and developing innovative teaching approaches. His recent publications reveal a clear research trajectory focused on improving diagnostic accuracy in glaucoma through advanced visual field testing techniques and novel instrumentation. Dr. Agar has been instrumental in validating web-based perimetry systems, developing AI applications for patient education in glaucoma care, and establishing protocols for early detection of visual field defects. His work bridges clinical practice with technological innovation, particularly in making diagnostic tools more accessible and cost-effective. Dr. Agar has demonstrated leadership in medical education research, particularly through systematic reviews documenting the global decline in ophthalmology education within medical curricula. His work extends to neuro-ophthalmology, with investigations into vision changes related to systemic conditions like diabetes and intracranial pressure assessment through ocular parameters. Throughout his career, Dr. Agar has collaborated extensively with ophthalmology departments across Australia and New Zealand, contributing to large-scale studies on glaucoma management and surgical practices. His research group has developed innovative approaches to visual field testing and has been at the forefront of integrating technology into routine ophthalmic practice.

• Ophthalmology
• Glaucoma
• Visual Field Testing
• +5 more

Dr. Zahra Tajbakhsh is a Lecturer at the Department of Optometry and Vision Science, School of Allied Health, The University of Western Australia. She holds a PhD in Optometry and Vision Science (2022) from UNSW Sydney, focusing on dendritic cells in ocular allergy, and earned her BOptom and MSc from Iran. Her research spans ocular surface disease, myopia control, contact lenses, and AI in retinal diagnostics, with over 28 publications and an h-index of 8. PhD, UNSW Sydney (2022): Dendritic cells in ocular allergy MSc in Optometry, Iran BOptom, Iran Dr. Tajbakhsh’s work integrates in vivo confocal microscopy with immunological studies to investigate conditions like allergic conjunctivitis, keratoconus, and LASIK recovery. Recent projects include AI-driven inherited retinal disease analysis and improving eye health literacy in Western Australia. She actively collaborates on ocular pressure dynamics, corneal structure, and pediatric vision research. Her publications highlight applications of AI in retinal diseases, keratoconus treatment, dendritic cell profiling, and pediatric ocular norms. Awards include recognition as an inaugural PhD Champion for UNSW Women in Math and Science. Current projects involve grants from the Perth Eye Foundation (2024–2027) to address eye health disparities. Inaugural PhD Champion, UNSW Women in Math and Science Dr. Tajbakhsh contributes to clinical research, teaching, and outreach, emphasizing diversity in STEM and advancing diagnostics for ocular conditions through interdisciplinary collaborations.

• Ocular Surface Disease
• Myopia Control
• In Vivo Confocal Microscopy
• +10 more

Andrea Curatolo is an Adjunct Research Fellow at the School of Engineering, University of Western Australia, specializing in Electrical, Electronic and Computer Engineering. He holds a PhD from the same university, focusing on improving optical coherence tomography (OCT) and elastography through optical beam shaping and simulations. His research emphasizes biomedical applications, particularly in ophthalmology and cancer diagnostics, contributing to UN Sustainable Development Goals in health and innovation. Key areas include corneal biomechanics, retinal imaging, and telehealth technologies like smartphone-based optical palpation for skin and breast tissue analysis. Collaborations span global institutions, advancing non-invasive diagnostic methods. Education: PhD in Optical Imaging Technologies (UWA, 2017); BSc and MSc from Polytechnic of Milan. Research interests integrate OCT, elastography, and machine learning to address challenges in ophthalmic surgery, cancer margin assessment, and telemedicine. His work bridges engineering and clinical needs, with over 46 publications and 1503 citations, reflecting contributions to high-resolution imaging and biomechanical analysis. Recent articles highlight advancements in spatio-temporal OCT (STOC-T) for retinal hemodynamics, chirped flicker optoretinography, and cross-meridian air-puff OCT for keratoconus detection. Innovations in low-cost imaging systems and robotic tool tracking aim to democratize medical diagnostics. His lab develops handheld elastography probes and smartphone-integrated palpation tools, advancing point-of-care solutions. Awards: While no specific honors are listed, his high citation count and h-index (21) underscore peer recognition. Supervised work includes mentoring students on biomechanical and imaging projects.

• Biomedical Engineering
• Medical Imaging
• Optical Coherence Tomography
• +3 more

Dr. Jed Lusthaus is a Clinical Associate Lecturer at the Central Clinical School, University of Sydney, affiliated with the Save Sight Institute. His research focuses on glaucoma, aqueous outflow dynamics, and intraocular pressure regulation through clinical and experimental studies. Recent publications highlight his work on aqueous outflow imaging using Hemoglobin Video Imaging, trabecular bypass devices like iStent Inject, and drug development for glaucoma and ocular hypertension. Key trends include in vivo visualization of aqueous dynamics, long-term surgical outcomes , and AI integration in glaucoma diagnosis.

• Glaucoma
• Ophthalmology
• Aqueous Outflow Imaging
• +5 more

Dr Vivek Pandya is a Clinical Lecturer at the University of Sydney and holds academic appointments at the University of New South Wales. He is affiliated with the Central Clinical School and the Save Sight Institute within the Faculty of Medicine and Health. His clinical expertise focuses on vitreoretinal surgery, medical retina, and complex cataract surgery. Dr Pandya completed his medical training at the University of New South Wales and ophthalmology residency at Sydney Eye Hospital, followed by subspecialty fellowships in medical retina (Westmead Hospital) and vitreoretinal surgery (University of British Columbia, Vancouver, Canada). He has been recognized with prestigious awards, including the RANZCO Leadership Grant and Excellence in Teaching Award. Education: BSc(Med) from University of New South Wales MBBS(Hons) from University of New South Wales MMed (Ophthalmic Science) from University of Sydney Research Interests: Dr Pandya’s work spans clinical and surgical advancements in retinal diseases, including age-related macular degeneration, diabetic retinopathy, and surgical innovations in retinal detachment repair. He actively contributes to clinical trials for novel retinal therapies and emphasizes international eye care initiatives in Cambodia and Fiji. Publications: His 15 most recent articles (2008–2017) focus on retinal pathology, ocular infections, and surgical outcomes. Key themes include choroidal neovascularisation, fungal keratitis, and tattoo-associated uveitis, reflecting his clinical expertise in complex retinal and infectious cases. Awards: 2020 RANZCO Leadership Grant Excellence in Teaching Award (2018) RANZCO/Bayer Scholarship Advising & Grants: Dr Pandya trains retinal fellows, ophthalmology registrars, and medical students. He has developed a vitreoretinal surgery unit at Liverpool Hospital and participates in international development programs. Labs/Teams: Involved with the Save Sight Institute and Retina Associates, contributing to clinical research and surgical innovation.

• Ophthalmology
• Vitreoretinal Surgery
• Medical Retina
• +3 more